Tryp Therapeutics Inc.
-
Head Office:
c/o Pushor Mitchell LLP, Kelowna, BC V1Y2B3 CAN -
Reporting Since:
2020-12-08Ceased to Be Reporting:
2024-05-31
Previous Names:
N/A
Year End:
August 31Principal Regulator:
British ColumbiaDefault History
| Period of Default | Default Code | Default From | Default To |
|---|---|---|---|
|
Q1 2023-11-30
|
1b.,1c.,1e.,3
|
2024-01-31
|
2024-02-05
|
Historical Exempt Distributions
Exempt Distribution filings made after 25-July-2023 can be viewed in SEDAR+
| Exemption | Document Type | Distribution From | Distribution To | $ Amount Raised | Filing Date |
|---|---|---|---|---|---|
|
NI 45-106 2.3
|
2022-07-08
|
2022-07-08
|
150000.0000
|
2022-07-18
|
|
|
NI 45-106 2.3
|
2021-02-16
|
2021-02-16
|
1999999.8000
|
2021-05-12
|
Exempt Applications & Orders
| Exemption Requested | Link to Order | Order date |
|---|---|---|
|
1996 Securities Act s. 88
|
2024-05-31
|
|
|
1996 Securities Act s. 88 Simplified Procedure
|
2024-05-31
|